Back to Search
VIVIAN SHI, M.D.
M.D.
Dermatology Physician
NPI: 1720333990IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD61517666(WA)
CMS Specialties
PrimaryDERMATOLOGY
Education
OTHER
Class of 2012
Research & Publications (17)
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.
PMID 19179299·J Clin Pharmacol·2009
2-rct
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
PMID 19052124·N Engl J Med·2008
4-observational
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
PMID 19040592·J Cardiometab Syndr·2008
4-observational
Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years.
PMID 18591457·Hypertension·2008
4-observational
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
PMID 18568687·Blood Press·2008
4-observational
Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
PMID 18374883·J Heart Lung Transplant·2008
7-preclinical
A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
PMID 18083195·J Theor Biol·2008
8-other
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.
PMID 18025153·Blood·2008
8-other
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
PMID 17612905·Blood Press·2007
2-rct
The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy.
PMID 17566314·Blood Press Suppl·2007
4-observational
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
PMID 17453747·Blood Press·2007
4-observational
Tegaserod does not alter fasting or meal-induced biliary tract motility.
PMID 15233676·Am J Gastroenterol·2004
3-trial
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.
PMID 15102696·Clin Cancer Res·2004
7-preclinical
T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
PMID 12042656·Transplantation·2002
7-preclinical
Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
PMID 12023620·Transplantation·2002
7-preclinical
Somatostatin receptors and the potential use of Sandostatin to interfere with vascular remodelling.
PMID 11068933·Eur J Endocrinol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1959 NE PACIFIC ST.
SEATTLE, WA 98195 - Phone
- (206) 520-5000
Quick Facts
- NPI
- 1720333990
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 14
- Publications
- 17
Are you this provider?
Claim Your Profile